Ahmedabad-based pharmaceutical/healthcare company listed on NSE's SME Emerge platform, operating through a network of related-party pharma trading and distribution entities.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 12 | 18 | 18 | 18 | 18 |
| Reserves | 1 | 10 | 14 | 14 | 14 |
| Borrowings | 40 | 41 | 54 | 55 | 56 |
| Other Liabilities | 9 | 12 | 25 | 33 | 34 |
| Total Liabilities | 63 | 81 | 110 | 119 | 122 |
| AssetsFixed Assets | 1 | 1 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 1 | 0 | 0 | 0 | 0 |
| Other Assets | 61 | 80 | 109 | 118 | 121 |
| Total Assets | 63 | 81 | 110 | 119 | 122 |
| Line item | FY23 | FY24 | FY25 |
|---|---|---|---|
| ActivitiesCash from Operating | -40 | -9 | -4 |
| Cash from Investing | -1 | 0 | 0 |
| Cash from Financing | 41 | 8 | 5 |
| SummaryCapital Expenditure | — | — | — |
| Free Cash Flow | -40 | -9 | -5 |
| FCF Margin | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
MONOPHARMA · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.